Moringa Acquisition Corp
Cash in trust
$5.9M
$5,924,118
Trust per share
$11.50
Redemption value
IPO
Feb 2021
$115.0M raised
Combination deadline
—
Not disclosed
Filings on record
105
Latest Aug 27, 2024
Business combination
- Target
- Not disclosed in an indexed filing
- Announced
- Jun 13, 2022
- Closed
- Aug 21, 2024
Overview
Moringa Acquisition Corp is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0001835416. It completed its initial public offering in Feb 2021, raising $115.0M in gross proceeds. The vehicle is sponsored by Moringa through Moringa Sponsor, LP. The mandate targets technology. Business combination closed; the company trades under a new ticker.
“we intend to focus our search on technology-based businesses that are domiciled in Israel, that carry out all or a substantial portion of their activities in Israel, or that have some other significant Israeli connection.”
Reading the filings
Arithmetic on what Moringa Acquisition Corp has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.
Trust versus the $10 unit
The trust holds $11.50 per public share, 15.0% above the $10.00 the units were sold at. That spread is accrued interest on the trust and, where the charter provides for it, sponsor contributions paid in to buy more time. It is the floor a public shareholder can redeem at, not a valuation of the business.
Underwriting
Moelis led the offering. It has been named on 12 SPAC IPOs, book-running 12 of them, and 8.3% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.
SEC filing history
Free tier: filings older than 24 hours- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001420506-24-001770
- 15-12G
Deregistration of securities
Accession 0001213900-24-072427
- 8-K
Entry into a material definitive agreement; Completion of an acquisition; Notice of delisting or failure to satisfy a listing rule; Other events
Items 1.01, 2.01, 3.01, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01 · Accession 0001213900-24-071449
- 25-NSE
Notification of delisting
Accession 0001354457-24-000575
- 10-Q
Quarterly report
Accession 0001213900-24-067989
- 8-K
Submission of matters to a vote of security holders
Item 5.07 · Accession 0001213900-24-067659
- 425
Business-combination communication
Accession 0001013762-24-001131
- 425
Business-combination communication
Accession 0001013762-24-001127
- DEFM14A
Definitive merger proxy statement
Accession 0001213900-24-061956
- 8-K
Entry into a material definitive agreement
Items 1.01, 9.01 · Accession 0001213900-24-055254
- 10-Q
Quarterly report
Accession 0001213900-24-043578
- 8-K
Entry into a material definitive agreement
Items 1.01, 9.01 · Accession 0001213900-24-029646
- 10-K
Annual report
Accession 0001213900-24-028721
- 8-K
Notice of delisting or failure to satisfy a listing rule
Item 3.01 · Accession 0001213900-24-016968
- 8-K
Entry into a material definitive agreement; Other events
Items 1.01, 8.01, 9.01 · Accession 0001213900-24-016967
- SC 13G/A
SC 13G/A
Accession 0001104659-24-022769
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0001315863-24-000206
- SC 13G/A
FORM SC 13G/A
Accession 0001062993-24-002424
- SC 13G
Beneficial ownership report (passive)
Accession 0001584639-24-000007
- 10-Q
Quarterly report
Accession 0001213900-23-086914
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0001076809-23-000245
- 4
Statement of changes in beneficial ownership
Accession 0001393825-23-000221
- 8-K
Entry into a material definitive agreement; Submission of matters to a vote of security holders; Other events
Items 1.01, 2.03, 5.03, 5.07, 8.01, 9.01 · Accession 0001213900-23-069929
- DEFA14A
Additional proxy soliciting material
Accession 0001213900-23-068005
- DEFA14A
Additional proxy soliciting material
Accession 0001213900-23-067478
- 8-K
Other events
Items 8.01, 9.01 · Accession 0001213900-23-067477
- 10-Q
Quarterly report
Accession 0001213900-23-067013
- DEFA14A
Additional proxy soliciting material
Accession 0001213900-23-065605
- 8-K
Termination of a material definitive agreement
Item 1.02 · Accession 0001213900-23-065593
- DEF 14A
Definitive proxy statement
Accession 0001213900-23-060024
Moringa Acquisition Corp: questions answered
What is Moringa Acquisition Corp?
Moringa Acquisition Corp is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0001835416. It completed its initial public offering in Feb 2021, raising $115.0M in gross proceeds. The vehicle is sponsored by Moringa through Moringa Sponsor, LP. The mandate targets technology. Business combination closed; the company trades under a new ticker.
How much does Moringa Acquisition Corp hold in trust?
Approximately $5,924,118, or about $11.50 per public share, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.
When must Moringa Acquisition Corp complete a merger?
No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.
What happens if Moringa Acquisition Corp does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in Moringa Acquisition Corp, and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date, most recently disclosed at about $11.50 per share. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
Is the trust value the same as the share price for Moringa Acquisition Corp?
No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.
Who sponsors Moringa Acquisition Corp, and what is their track record?
Moringa Sponsor, LP is the sponsor entity, part of the Moringa franchise. This is the only vehicle we have attributed to that sponsor. Named principals: Ilan Levin.
Which banks underwrote the Moringa Acquisition Corp IPO?
EarlyBirdCapital, Moelis, R. F. Lafferty &. Moelis was credited as book-running manager on the cover. Syndicate membership and role are read from the prospectus cover and the underwriting section.
Is Moringa Acquisition Corp a good investment?
That is not a question this site answers. Moringa Acquisition Corp is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this Moringa Acquisition Corp data come from?
Filings Moringa Acquisition Corp submitted to the SEC under CIK 0001835416: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Sep 4, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
Moringa: the full record
Every vehicle this sponsor has launched, what closed, what liquidated and what is still live.
Moelis in SPACs
Mandates, bookrun credit, deal volume and the outcome of the vehicles it priced.
Technology SPACs
Every vehicle chasing the same mandate, ranked by cash in trust.
All completed de-spac transactions
Business combination closed; the company trades under a new ticker.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.